| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CFO & General Counsel
2 companies
Sandip I Patel is CFO & General Counsel at ATCH and has filed Form 4s across 2 companies. Sandip I Patel's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $442K at current prices.
The biggest single holding is AKTX (~$317K) as Director.
Sandip I Patel has 8 Form 4 filings on record from February 2024 to October 2026, across 2 companies: CFO and General Counsel at Quantum FinTech Acquisition Cor (ATCH), 2024–2026; Director at Akari Therapeutics (AKTX), 2025–2026.
The 22 reported transactions were 9 option or other derivative awards, 5 stock awards, 4 open-market purchases and 2 option exercises, plus smaller numbers of other types.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria